Inhibrx Inc. Ex-distribut... (INBXV)
NASDAQ: INBXV
· Real-Time Price · USD
30.85
0.00 (0.00%)
At close: Jun 17, 2025, 10:00 PM
Company Description
No Company description available at the moment.
Inhibrx Inc. Ex-distribution When-Issued
| Country | n/a |
| IPO Date | n/a |
| Industry | |
| Sector | n/a |
| Employees | 166 |
| CEO | Mark Paul Lappe |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | INBXV |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Mark Paul Lappe | Founder, Chairman, President & Chief Executive Officer |
| David Matly M.B.A. | Executive Vice President and Chief Commercial & Business Development Officer |
| Dr. Ashraf Amanullah | Executive Vice President & Chief Technical Operations Officer |
| Dr. Brendan P. Eckelman Ph.D. | Founder & Chief Scientific Officer |
| Dr. Carlos Bais Ph.D. | Executive Vice President of Translational Sciences |
| Dr. Charbel Helaihel Pharm.D. | Vice President of Marketing & Commercial Planning |
| Dr. Josep Garcia Ph.D. | EVice President & Chief Clinical Development Officer |
| Jeffrey J. Jensen | Executive Vice President & Chief Clinical Operations Officer |
| Leah Pollema J.D. | Vice President, Corporate Secretary & General Counsel |
| Quinn L. Deveraux | Founder |